Skip to content

In the BioHarmony Drug Report Database

Valproic acid

Depakene, Stavzor (valproic acid) is a small molecule pharmaceutical. Valproic acid was first approved as Depakene on 1982-01-01. It is used to treat absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, and epilepsy amongst others in the USA. It is known to target histone deacetylase 1.
Trade Name Depakene, Stavzor
Common Name Valproic acid
Indication absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, epilepsy, mood disorders
Drug Class
Valproic acid
Get full access now